Strategic approach to mental health assessment and management for MCCQE candidates.
Major Depressive Disorder (MDD) and Bipolar Disorder are high-frequency topics. For MDD, remember the SIGECAPS mnemonic for diagnosis. In Bipolar, distinguishing between Type I (Manic) and Type II (Hypomanic + MDD) is essential for correct management.
Diagnosis requires at least 6 months of symptoms, including positive symptoms (hallucinations, delusions) and negative symptoms (apathy, social withdrawal). Second-generation antipsychotics (e.g., Risperidone, Quetiapine) are generally first-line due to lower risk of extrapyramidal side effects.
The MCCQE frequently tests the legal aspects of psychiatric care in Canada. Involuntary admission (e.g., Form 1 in Ontario) is indicated if a patient is a danger to themselves or others, or if they are unable to care for themselves due to mental illness.
Screening for alcohol and drug use is vital. Be familiar with the management of withdrawal syndromes, particularly alcohol withdrawal (delirium tremens), which is a medical emergency managed with benzodiazepines.